Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans

This publication has 31 references indexed in Scilit:

• Polymorphisms in the Nonmuscle Myosin Heavy Chain 9 Gene (MYH9) Are Associated with Albuminuria in Hypertensive African Americans: The HyperGEN Study
  American Journal of Nephrology, 2009
• MYH9 is associated with nondiabetic end-stage renal disease in African Americans
  Nature Genetics, 2008
• MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
  Nature Genetics, 2008
• TRPC6 and FSGS: The latest TRP channelopathy
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
• Estimation of individual admixture: Analytical and study design considerations
  Genetic Epidemiology, 2005
• Haploview: analysis and visualization of LD and haplotype maps
  Bioinformatics, 2004
• A High-Density Admixture Map for Disease Gene Discovery in African Americans
  American Journal of Human Genetics, 2004
• Renal Biopsy Findings in Presumed Hypertensive Nephrosclerosis
  American Journal of Nephrology, 1994
• Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.
  Hypertension, 1989
• Renal Insufficiency in Treated Essential Hypertension
  New England Journal of Medicine, 1989